Drug: symbicort Quarter: 2016Q3
Total Records: 697 Number of Pages: 35
DRUGNAME | PT | EventCount |
---|---|---|
SYMBICORT | Cardio-respiratory arrest | 3 |
SYMBICORT | Deep vein thrombosis | 3 |
SYMBICORT | Diabetic neuropathy | 3 |
SYMBICORT | Drug administered to patient of inappropriate age | 3 |
SYMBICORT | Drug dispensing error | 3 |
SYMBICORT | Drug interaction | 3 |
SYMBICORT | Eye swelling | 3 |
SYMBICORT | Fear | 3 |
SYMBICORT | Fibroma | 3 |
SYMBICORT | Glucose tolerance impaired | 3 |
SYMBICORT | Goitre | 3 |
SYMBICORT | Hepatic cancer | 3 |
SYMBICORT | Ill-defined disorder | 3 |
SYMBICORT | Lower respiratory tract infection | 3 |
SYMBICORT | Lung carcinoma cell type unspecified recurrent | 3 |
SYMBICORT | Lung carcinoma cell type unspecified stage IV | 3 |
SYMBICORT | Mobility decreased | 3 |
SYMBICORT | Mouth ulceration | 3 |
SYMBICORT | Nasal polyps | 3 |
SYMBICORT | Obstructive airways disorder | 3 |
Total Records: 697 Number of Pages: 35